Litcius/Paper detail

Fluoroquinolone resistance determinants in carbapenem-resistant <i>Escherichia coli</i> isolated from urine clinical samples in Thailand

Parichart Boueroy, Peechanika Chopjitt, Rujirat Hatrongjit, Masatomo Morita, Yo Sugawara, Yukihiro Akeda, Tetsuya Iida, Shigeyuki Hamada, Anusak Kerdsin

2023PeerJ15 citationsDOIOpen Access PDF

Abstract

Background Escherichia coli is the most common cause of urinary tract infections and has fluoroquinolone (FQ)-resistant strains, which are a worldwide concern. Objectives To characterize FQ-resistant determinants among 103 carbapenem-resistant E. coli (CREc) urinary isolates using WGS. Methods Antimicrobial susceptibility, biofilm formation, and short-read sequencing were applied to these isolates. Complete genome sequencing of five CREcs was conducted using short- and long-read platforms. Results ST410 (50.49%) was the predominant ST, followed by ST405 (12.62%) and ST361 (11.65%). Clermont phylogroup C (54.37%) was the most frequent. The genes NDM-5 (74.76%) and CTX-M-15 (71.84%) were the most identified. Most CREcs were resistant to ciprofloxacin (97.09%) and levofloxacin (94.17%), whereas their resistance rate to nitrofurantoin was 33.98%. Frequently, the gene aac(6′)-Ib (57.28%) was found and the coexistence of aac(6′)-Ib and bla CTX-M-15 was the most widely predominant. All isolates carried the gyrA mutants of S83L and D87N. In 12.62% of the isolates, the coexistence was detected of gyrA , gyrB , parC , and parE mutations. Furthermore, the five urinary CREc-complete genomes revealed that bla NDM-5 or bla NDM-3 were located on two plasmid Inc types, comprising IncFI (60%, 3/5) and IncFI/IncQ (40%, 2/5). In addition, both plasmid types carried other resistance genes, such as bla OXA-1 , bla CTX-M-15 , bla TEM-1B , and aac(6′)-Ib . Notably, the IncFI plasmid in one isolate carried three copies of the bla NDM-5 gene. Conclusions This study showed FQ-resistant determinants in urinary CREc isolates that could be a warning sign to adopt efficient strategies or new control policies to prevent further spread and to help in monitoring this microorganism.

Topics & Concepts

MicrobiologyEscherichia coliPlasmidBiologyCiprofloxacinCarbapenemLevofloxacinGeneGeneticsAntibioticsAntibiotic Resistance in BacteriaUrinary Tract Infections ManagementBacterial Identification and Susceptibility Testing
Fluoroquinolone resistance determinants in carbapenem-resistant <i>Escherichia coli</i> isolated from urine clinical samples in Thailand | Litcius